BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samsky M, Krucoff M, Althouse AD, Abraham WT, Adamson P, Aguel F, Bilazarian S, Dangas GD, Gilchrist IC, Henry TD, Hochman JS, Kapur NK, Laschinger J, Masters RG, Michelson E, Morrow DA, Morrow V, Ohman EM, Pina I, Proudfoot AG, Rogers J, Sapirstein J, Senatore F, Stockbridge N, Thiele H, Truesdell AG, Waksman R, Rao S. Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. Am Heart J 2020;219:1-8. [PMID: 31707323 DOI: 10.1016/j.ahj.2019.10.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Piña IL, Gibson GT, Zieroth S, Kataria R. Reflecting on the advancements of HFrEF therapies over the last two decades and predicting what is yet to come. Eur Heart J Suppl 2022;24:L2-9. [PMID: 36545229 DOI: 10.1093/eurheartjsupp/suac112] [Reference Citation Analysis]
2 Tehrani BN, Sherwood MW, Rosner C, Truesdell AG, Ben Lee S, Damluji AA, Desai M, Desai S, Epps KC, Flanagan MC, Howard E, Ibrahim N, Kennedy J, Moukhachen H, Psotka M, Raja A, Saeed I, Shah P, Singh R, Sinha SS, Tang D, Welch T, Young K, deFilippi CR, Speir A, O’connor CM, Batchelor WB. A Standardized and Regionalized Network of Care for Cardiogenic Shock. JACC: Heart Failure 2022;10:768-781. [DOI: 10.1016/j.jchf.2022.04.004] [Reference Citation Analysis]
3 Damluji AA, Tehrani B, Sinha SS, Samsky MD, Henry TD, Thiele H, West NE, Senatore FF, Truesdell AG, Dangas GD, Smilowitz NR, Amin AP, deVore AD, Moazami N, Cigarroa JE, Rao SV, Krucoff MW, Morrow DA, Gilchrist IC. Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock. JACC: Cardiovascular Interventions 2022;15:2003-2019. [DOI: 10.1016/j.jcin.2022.08.041] [Reference Citation Analysis]
4 Kapur NK, Kanwar M, Sinha SS, Thayer KL, Garan AR, Hernandez-Montfort J, Zhang Y, Li B, Baca P, Dieng F, Harwani NM, Abraham J, Hickey G, Nathan S, Wencker D, Hall S, Schwartzman A, Khalife W, Li S, Mahr C, Kim JH, Vorovich E, Whitehead EH, Blumer V, Burkhoff D. Criteria for Defining Stages of Cardiogenic Shock Severity. J Am Coll Cardiol 2022;80:185-98. [PMID: 35835491 DOI: 10.1016/j.jacc.2022.04.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Elgendy IY, Wegermann ZK, Li S, Mahtta D, Grau-Sepulveda M, Smilowitz NR, Gulati M, Garratt KN, Wang TY, Jneid H. Sex Differences in Management and Outcomes of Acute Myocardial Infarction Patients Presenting With Cardiogenic Shock. JACC Cardiovasc Interv 2022;15:642-52. [PMID: 35331456 DOI: 10.1016/j.jcin.2021.12.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
6 Gorder K, Rudick S, Smith TD. Advocacy and Legislation for Regionalization Practices in the Treatment of Cardiogenic Shock: The Time Is Now. US Cardiology Review 2022;16:e06. [DOI: 10.15420/usc.2021.14] [Reference Citation Analysis]
7 Megaly M, Buda K, Alaswad K, Brilakis ES, Dupont A, Naidu S, Ohman M, Napp LC, O'Neill W, Basir MB. Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries. JACC Cardiovasc Interv 2022;15:297-304. [PMID: 35144785 DOI: 10.1016/j.jcin.2021.11.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Vallabhajosyula S. Trials, Tribunals, and Opportunities in Cardiogenic Shock Research. JACC Cardiovasc Interv 2022;15:305-7. [PMID: 35144786 DOI: 10.1016/j.jcin.2021.12.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ott S, Leser L, Lanmüller P, Just IA, Leistner DM, Potapov E, O’brien B, Klages J. Cardiogenic Shock Management and Research: Past, Present, and Future Outlook. US Cardiology Review 2022;16:e03. [DOI: 10.15420/usc.2021.25] [Reference Citation Analysis]
10 Truesdell AG. The Contemporary Cardiogenic Shock ‘Playbook’. US Cardiology Review 2021;15:e24. [DOI: 10.15420/usc.2020.28] [Reference Citation Analysis]
11 Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV. Cardiogenic Shock After Acute Myocardial Infarction: A Review. JAMA 2021;326:1840-50. [PMID: 34751704 DOI: 10.1001/jama.2021.18323] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
12 Warren AF, Rosner C, Gattani R, Truesdell AG, Proudfoot AG. Cardiogenic Shock: Protocols, Teams, Centers, and Networks. US Cardiology Review 2021;15:e18. [DOI: 10.15420/usc.2021.10] [Reference Citation Analysis]
13 Alvarez Villela M, Clark R, William P, Sims DB, Jorde UP. Systems of Care in Cardiogenic Shock. Front Cardiovasc Med 2021;8:712594. [PMID: 34616782 DOI: 10.3389/fcvm.2021.712594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, Damluji AA, Batchelor WB. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. JACC Heart Fail 2020;8:879-91. [PMID: 33121700 DOI: 10.1016/j.jchf.2020.09.005] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 31.5] [Reference Citation Analysis]
15 Tyler JM, Brown C, Jentzer JC, Baran DA, van Diepen S, Kapur NK, Garberich RF, Garcia S, Sharkey SW, Henry TD. Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials. Catheter Cardiovasc Interv 2021. [PMID: 33871159 DOI: 10.1002/ccd.29710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Samsky MD, Krucoff MW, Morrow DA, Abraham WT, Aguel F, Althouse AD, Chen E, Cigarroa JE, DeVore AD, Farb A, Gilchrist IC, Henry TD, Hochman JS, Kapur NK, Morrow V, Ohman EM, O'Neill WW, Piña IL, Proudfoot AG, Sapirstein JS, Seltzer JH, Senatore F, Shinnar M, Simonton CA, Tehrani BN, Thiele H, Truesdell AG, Waksman R, Rao SV. Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. Am Heart J 2020;230:93-7. [PMID: 33011148 DOI: 10.1016/j.ahj.2020.09.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Wang JI, Lu DY, Mhs, Feldman DN, McCullough SA, Goyal P, Karas MG, Sobol I, Horn EM, Kim LK, Krishnan U. Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non-Left Ventricular Assist Device Centers. J Am Heart Assoc 2020;9:e017326. [PMID: 33222608 DOI: 10.1161/JAHA.120.017326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Wegermann ZK, Rao SV. Currently Available Options for Mechanical Circulatory Support for the Management of Cardiogenic Shock. Cardiol Clin 2020;38:527-42. [PMID: 33036715 DOI: 10.1016/j.ccl.2020.06.006] [Reference Citation Analysis]
19 Truesdell AG, Sauer AJ, Alasnag M. Known Knowns, Known Unknowns, and Unknown Unknowns. Cardiovasc Revasc Med 2020;21:1472-3. [PMID: 32988744 DOI: 10.1016/j.carrev.2020.09.023] [Reference Citation Analysis]